These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 16295159)

  • 21. ACOG releases guidelines on diagnosis and management of polycystic ovary syndrome.
    Schroeder BM;
    Am Fam Physician; 2003 Apr; 67(7):1619-20, 1622. PubMed ID: 12722867
    [No Abstract]   [Full Text] [Related]  

  • 22. The patient with polycystic ovary syndrome.
    Hoo P; Shaw R
    Practitioner; 2005 Aug; 249(1673):552, 555-7, 559-10. PubMed ID: 16108473
    [No Abstract]   [Full Text] [Related]  

  • 23. Spironolactone for hirsutism in polycystic ovary syndrome.
    Christy NA; Franks AS; Cross LB
    Ann Pharmacother; 2005 Sep; 39(9):1517-21. PubMed ID: 16076921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of metformin in the treatment of polycystic ovary syndrome (PCOS).
    Wang HS
    Chang Gung Med J; 2006; 29(5):445-7. PubMed ID: 17214387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimal management of polycystic ovary syndrome in adolescence.
    Hecht Baldauff N; Arslanian S
    Arch Dis Child; 2015 Nov; 100(11):1076-83. PubMed ID: 26101431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug treatments for polycystic ovary syndrome.
    Radosh L
    Am Fam Physician; 2009 Apr; 79(8):671-6. PubMed ID: 19405411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women: do we need a new drug?
    Legro RS
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4218-20. PubMed ID: 18987279
    [No Abstract]   [Full Text] [Related]  

  • 28. Polycystic ovary syndrome.
    Aherne SA
    Nurs Stand; 2004 Mar 10-16; 18(26):40-4. PubMed ID: 15052762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of metformin in the management of polycystic ovary syndrome and associated anovulatory infertility: the current evidence.
    Leeman L; Acharya U
    J Obstet Gynaecol; 2009 Aug; 29(6):467-72. PubMed ID: 19697191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Advance in treatment of polycystic ovary syndrome].
    Krysiak R; Okopień B; Herman ZS
    Pol Merkur Lekarski; 2005 Dec; 19(114):848-54. PubMed ID: 16521439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nurse-led peer support group: experiences of women with polycystic ovary syndrome.
    Percy CA; Gibbs T; Potter L; Boardman S
    J Adv Nurs; 2009 Oct; 65(10):2046-55. PubMed ID: 19686401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome].
    Otto-Buczkowska E; Jarosz-Chobot P; Deja G
    Przegl Lek; 2006; 63(4):234-8. PubMed ID: 17080748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndrome.
    Glueck CJ; Pranikoff J; Aregawi D; Wang P
    Fertil Steril; 2008 Mar; 89(3):625-34. PubMed ID: 17678910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in weight, papilledema, headache, visual field, and life status in response to diet and metformin in women with idiopathic intracranial hypertension with and without concurrent polycystic ovary syndrome or hyperinsulinemia.
    Glueck CJ; Golnik KC; Aregawi D; Goldenberg N; Sieve L; Wang P
    Transl Res; 2006 Nov; 148(5):215-22. PubMed ID: 17145568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polycystic ovarian syndrome in adolescents.
    Creatsas G; Deligeoroglou E
    Curr Opin Obstet Gynecol; 2007 Oct; 19(5):420-6. PubMed ID: 17885456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Pregnancy in Polycystic Ovary Syndrome study: baseline characteristics of the randomized cohort including racial effects.
    Legro RS; Myers ER; Barnhart HX; Carson SA; Diamond MP; Carr BR; Schlaff WD; Coutifaris C; McGovern PG; Cataldo NA; Steinkampf MP; Nestler JE; Gosman G; Guidice LC; Leppert PC;
    Fertil Steril; 2006 Oct; 86(4):914-33. PubMed ID: 16963034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obesity and the polycystic ovary syndrome.
    Martínez-Bermejo E; Luque-Ramírez M; Escobar-Morreale HF
    Minerva Endocrinol; 2007 Sep; 32(3):129-40. PubMed ID: 17912153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Everything old is new again: spironolactone and metformin in the treatment of acne.
    Bergstrom KG
    J Drugs Dermatol; 2010 May; 9(5):569-71. PubMed ID: 20480804
    [No Abstract]   [Full Text] [Related]  

  • 39. Prenatal growth restraint followed by catch-up of weight: a hyperinsulinemic pathway to polycystic ovary syndrome.
    de Zegher F; Ibáñez L
    Fertil Steril; 2006 Jul; 86 Suppl 1():S4-5. PubMed ID: 16798286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends, in Diagnosis and Treatment of Polycystic Ovarian Syndrome by Specialty.
    Uliassi N; Sullivan S; Damle L; Gomez-Lobo V
    J Reprod Med; 2016 Sep; 61(9-10):441-446. PubMed ID: 30383942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.